Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr

What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Financing Activities ratio of NATCO PHARMA is ₹-211 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-211 Cr
Mar2024₹-247 Cr
Mar2023₹-363 Cr
Mar2022₹35 Cr
Mar2021₹-186 Cr

How is Cash Flow from Financing Activities of NATCO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-211 Cr
Negative
Mar2024 ₹-247 Cr
Negative
Mar2023 ₹-363 Cr
Negative
Mar2022 ₹35 Cr
Positive
Mar2021 ₹-186 Cr -

Compare Cash Flow from Financing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,474.5 Cr -0.8% -1.5% -6.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0.8%

-1.5%

-6.7%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses